EUVIMEDEUVIMED entdecken
Crossref

AGFG1 increases cholesterol biosynthesis by disrupting intracellular cholesterol homeostasis to promote PDAC progression

Zonghao Duan, Minwei Yang, Jian Yang, Zheng Wu, Yuheng Zhu, Qinyuan Jia, Xueshiyu Ma, Yifan Yin, Jiahao Zheng, Jianyu Yang, Shuheng Jiang, Lipeng Hu und 5 weitere

Cancer Letters · 2024-08 · 598 · 217130

DOI: 10.1016/j.canlet.2024.217130 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2024-08. Verfasst von Zonghao Duan und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biliary-Pancreatic Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, PR China; State Key L…. Hauptthemen laut MEDLINE: Cholesterol, Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms, Cell Proliferation. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 66 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Cholesterol metabolism reprograming has been acknowledged as a novel feature of cancers. Pancreatic ductal adenocarcinoma (PDAC) is a cancer with a high demand of cholesterol for rapid growth. The underlying mechanism of how cholesterol metabolism homestasis are disturbed in PDAC is explored. EXPERIMENTAL DESIGN: The relevance between PDAC and cholesterol was confirmed in TCGA database. The expression and clinical association were discovered in TCGA and GEO datasets. Knockdown and overexpression of AGFG1 was adopted to perform function studies. RNA sequencing, cholesterol detection, transmission electron microscope, co-immunoprecipitation, and immunofluorescence et al. were utilized to reveal the underlying mechanism. RESULTS: AGFG1 was identified as one gene positively correlated with cholesterol metabolism in PDAC as revealed by bioinformatics analysis. AGFG1 expression was then found associated with poor prognosis in PDAC. AGFG1 knockdown led to decreased proliferation of tumor cells both in vitro and in vivo. By RNA sequencing, we found AGFG1 upregulated expression leads to enhanced intracellular cholesterol biosynthesis. AGFG1 knockdown suppressed cholesterol biosynthesis and an accumulation of cholesterol in the ER. Mechanistically, we confirmed that AGFG1 interacted with CAV1 to relocate cholesterol for the proceeding of cholesterol biosynthesis, therefore causing disorders in intracellular cholesterol metabolism. CONCLUSIONS: Our study demonstrates the tumor-promoting role of AGFG1 by disturbing cholesterol metabolism homestasis in PDAC. Our study has present a new perspective on cancer therapeutic approach based on cholerstrol metabolism in PDAC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholesterolCarcinoma, Pancreatic DuctalPancreatic NeoplasmsCell ProliferationHomeostasisHumansAnimalsCell Line, TumorMiceGene Expression Regulation, NeoplasticDisease ProgressionPrognosisCaveolin 1Mice, NudeMale

Stichwörter der Autor:innen

AGFG1Cholesterol biosynthesisCholesterol transportationPDAC

Substanzen

CholesterolCaveolin 1

Autor:innen und Institutionen

  • Department of Biliary-Pancreatic Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, PR China; State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, R…
  • Department of Biliary-Pancreatic Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, PR China.
  • Department of Radiation Oncology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, PR China.
  • State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200240, PR China.
  • Department of Biliary-Pancreatic Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, PR China; Department of General Surgery, Jiading District Central Hospital Affiliated Shang…
  • Department of Biliary-Pancreatic Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, PR China. Electronic address: liudejun@renji.com.

Zitieren

APA

Duan, Z., Yang, M., Yang, J., Wu, Z., Zhu, Y., Jia, Q., Ma, X., Yin, Y., Zheng, J., Yang, J., Jiang, S., Hu, L., Zhang, J., Liu, D., Huo, Y., Yao, L., & Sun, Y. (2024). AGFG1 increases cholesterol biosynthesis by disrupting intracellular cholesterol homeostasis to promote PDAC progression. Cancer Letters, 598, 217130. https://doi.org/10.1016/j.canlet.2024.217130

Vancouver

Duan Z, Yang M, Yang J, Wu Z, Zhu Y, Jia Q, et al. AGFG1 increases cholesterol biosynthesis by disrupting intracellular cholesterol homeostasis to promote PDAC progression. Cancer Letters. 2024;598:217130. doi:10.1016/j.canlet.2024.217130

BibTeX
@article{Duan2024,
  author = {Duan, Zonghao and Yang, Minwei and Yang, Jian and Wu, Zheng and Zhu, Yuheng and Jia, Qinyuan and Ma, Xueshiyu and Yin, Yifan and Zheng, Jiahao and Yang, Jianyu and Jiang, Shuheng and Hu, Lipeng and Zhang, Junfeng and Liu, Dejun and Huo, Yanmiao and Yao, Linli and Sun, Yongwei},
  title = {AGFG1 increases cholesterol biosynthesis by disrupting intracellular cholesterol homeostasis to promote PDAC progression},
  journal = {Cancer Letters},
  year = {2024},
  volume = {598},
  pages = {217130},
  doi = {10.1016/j.canlet.2024.217130}
}
Kostenlos starten →